Leukapheresis to prepare CAR cell therapy
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial collects white blood cells through a procedure called leukapheresis to help make CAR or other adoptive cell therapies. It’s for people with certain cancers who are not in remission (or are at high risk of relapse) and can meet health and lab requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 3 and 65 years old, and you weigh at least 15 kg
- Your cancer diagnosis must be confirmed (by approved lab tests or biopsy results)
- Your cancer is either not in remission after relapse/refractory disease, or you’re disease-free but at high risk to relapse
- Your blood counts and liver/kidney tests must meet study targets (with a few disease-related exceptions)
- You must be able to give consent (a parent/guardian can consent for children, if needed)
- You must not have certain exclusions like pregnancy, uncontrolled infection, or HIV
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a type of immunotherapy called CAR-T cells that are made from your own blood cells and are designed to find and destroy leukemia cells. It is for patients whose leukemia has come back or hasn't gone away after other treatments.
This trial tests an immunotherapy called CAR T cells for leukemia that has come back or is hard to treat. It aims to use your own immune cells to fight the cancer.
This early-phase trial tests CAR T-cells made to attack leukemia cells with specific markers (CD19 and CD22). It may help people with difficult-to-treat, relapsed, or high-risk acute lymphoblastic leukemia (ALL), especially when standard treatments haven’t worked well.
This trial tests a new treatment using specially engineered immune cells (CAR-NK cells) that are designed to find and destroy leukemia cells. It may be an option for patients whose leukemia has come back or hasn't responded to other treatments.
This study tests a new type of immune therapy called CAR-T cells, which are made from your own blood cells to find and attack cancer. It is for adults with leukemia or lymphoma that has come back or is hard to treat.
This trial tests giving special immune cells (CAR T cells) after a half-matched stem cell transplant. It's for children and young adults with high-risk leukemia or lymphoma that has come back or not responded to treatment.
Hear when a new Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.